ICMR’s Breakthrough Pill May Help Prevent Which Cancer? | Current Affairs 2026 | Health MCQ

In July 2026, the Indian Council of Medical Research (ICMR) announced a major breakthrough with an indigenous oral therapeutic candidate called SHetA2, developed to help prevent cervical cancer. The pill targets Human Papillomavirus (HPV)-related Cervical Intraepithelial Neoplasia (CIN) by blocking the virus’s cancer-causing proteins, potentially preventing the progression to cervical cancer. The technology has been licensed to Emcure Pharmaceuticals for further development and commercialization.

📚 MCQ:
In July 2026, the Indian Council of Medical Research (ICMR) announced a breakthrough pill to help prevent which type of cancer?

✅ Answer: Cervical Cancer

✅ In this video, you’ll learn:

The correct answer to the MCQ
What the SHetA2 breakthrough pill is
How HPV is linked to cervical cancer
The role of ICMR in developing indigenous medical innovations
Important Health, Medical Science, and Current Affairs facts for UPSC, SSC, Banking, Railways, CDS, NDA, CUET, State PCS, and other competitive examinations

🎯 Strengthen your Health GK, Medical Science, Biotechnology, and Current Affairs with exam-oriented MCQs.

📌 Like 👍 | Share 📤 | Subscribe 🔔 for Daily Current Affairs, Health News, Science Updates, Static GK, and MCQ-based learning.

#CurrentAffairs #CurrentAffairs2026 #ICMR #CervicalCancer #HPV #MedicalScience #Healthcare #ScienceAndTechnology #UPSC #SSC #BankingExams #GK #MCQ

ICMR, Cervical Cancer, SHetA2, HPV, Emcure Pharmaceuticals, Medical Science Current Affairs, Health Current Affairs, Biotechnology, Current Affairs 2026, UPSC Current Affairs, SSC GK, Banking Exams, Railway Exams, Health GK, Competitive Exams